GlassScriptPhysician profile
Richard C Manus
NPI 1033241104
$4,654.51
in general payments reported to CMS, 2019-2025
11 companies · $2,111 in 2025
The $2,111 reported for 2025 was more than what 92% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,716 · 2020: $50.51 · 2021: $267 · 2022: $90.41 · 2023: $241 · 2024: $178 · 2025: $2,111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,279 · Food and Beverage: $934 · Education: $317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,278.89 |
| Food and Beverage | $934.30 |
| Education | $317.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $2,298.09 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $1,753.18 | 2019-2021 | |
| Kls-Martin L.P. | $212.88 | 2019-2024 | |
| Straumann USA LLC | $79.93 | 2022-2023 | |
| Salvin Dental Specialties, INC. | $74.45 | 2019 | |
| Novo Nordisk INC | $66.62 | 2020-2021 | |
| Keystone Dental INC. | $63.16 | 2019 | |
| Depuy Synthes Sales INC. | $54.92 | 2019 | |
| Biohorizons Implant Systems INC. | $18.88 | 2025 | Biohorizons Dental Implants |
| Kowa Pharmaceuticals America, INC. | $17.73 | 2022 | |
| Geistlich Pharma, North America, INC. | $14.67 | 2024 | Geistlich Bio-Gide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Manus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.